Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Depression Blog

Blog
The Psychedelic Aspect of Esketamine is an Opportunity, Not a Side Effect
05/23/2019
Andrew Penn, RN, MS, NP, CNS, APRN-BC
BLOG: Esketamine represents the first psychedelic treatment approved by the FDA for a psychiatric condition.
BLOG: Esketamine represents the first psychedelic treatment approved by the FDA for a psychiatric condition.
BLOG: Esketamine represents the...
05/23/2019
Psych Congress Network
Andrew Penn
Blog
Defeating Depression by Reconnecting With Others and the World
11/30/2018
Andrew Penn, RN, MS, NP, CNS, APRN-BC
BLOG: This year’s Psych Congress returned, time and again, to the theme of us needing to reconnect with a larger experience of the world in order to find a path out of depression.
BLOG: This year’s Psych Congress returned, time and again, to the theme of us needing to reconnect with a larger experience of the world in order to find a path out of depression.
BLOG: This year’s Psych Congress...
11/30/2018
Psych Congress Network
Blog
Screening for Perinatal Depression Is Not Enough
07/11/2018
BLOG: The logical endpoint of population-based screening for perinatal depression is remission of depression in those who screen positive. Otherwise screening is just an empty endeavor.
BLOG: The logical endpoint of population-based screening for perinatal depression is remission of depression in those who screen positive. Otherwise screening is just an empty endeavor.
BLOG: The logical endpoint...
07/11/2018
Psych Congress Network

Advertisement

Blog
A Turning Point for Psychedelics?
06/06/2018
Andrew Penn, RN, MS, NP, CNS, APRN-BC
BLOG: Michael Pollan, author of The Omnivore’s Dilemma and The Botany of Desire, has turned his spotlight of curiosity onto the subject of psychedelics with his new book How to Change Your Mind.
BLOG: Michael Pollan, author of The Omnivore’s Dilemma and The Botany of Desire, has turned his spotlight of curiosity onto the subject of psychedelics with his new book How to Change Your Mind.
BLOG: Michael Pollan, author of...
06/06/2018
Psych Congress Network
Blog
Mothers Are Falling Through the Cracks: Let’s Make a Net for Them
04/26/2018
BLOG: On January 18, 2018, in Sacramento California, new mother Jessica Porten went to see a women’s health nurse practitioner. She was 4 months postpartum and had not been seen by her obstetric provider since giving birth.
BLOG: On January 18, 2018, in Sacramento California, new mother Jessica Porten went to see a women’s health nurse practitioner. She was 4 months postpartum and had not been seen by her obstetric provider since giving birth.
BLOG: On January 18, 2018, in...
04/26/2018
Psych Congress Network
Blog
Depression as Disconnection: New Lessons From Psychedelic Psychotherapy Studies
11/02/2017
Andrew Penn, RN, MS, NP, CNS, APRN-BC
BLOG: Recent qualitative studies on subjects treated with psilocybin may begin to help us understand the subjective experience caused by the drug that may lead to its antidepressant effects.
BLOG: Recent qualitative studies on subjects treated with psilocybin may begin to help us understand the subjective experience caused by the drug that may lead to its antidepressant effects.
BLOG: Recent qualitative studies...
11/02/2017
Psych Congress Network

Advertisement

Blog
The Psychiatrist as Patient: Do We Always Get Good Care in Our Hour of Need?
10/18/2017
BLOG: We psychiatrists read so much about physicians being “difficult patients.” What about when the shoe is on the other foot?
BLOG: We psychiatrists read so much about physicians being “difficult patients.” What about when the shoe is on the other foot?
BLOG: We psychiatrists read...
10/18/2017
Psych Congress Network
Blog
Psilocybin Studies: A New Ray of Hope for Psychiatry?
12/01/2016
Andrew Penn, RN, MS, NP, CNS, APRN-BC
BLOG: These studies were the latest findings showing that psychedelics, erroneously dismissed as mere intoxicants and swept up in the hysteria of the Nixon-era drug wars, could prove to be as important to psychiatry as penicillin was to...
BLOG: These studies were the latest findings showing that psychedelics, erroneously dismissed as mere intoxicants and swept up in the hysteria of the Nixon-era drug wars, could prove to be as important to psychiatry as penicillin was to...
BLOG: These studies were the...
12/01/2016
Psych Congress Network
Blog
Increasing Suicide Rates
05/27/2016
We need to get the message out that for every death by suicide there is a cohort of bereaved family members who themselves become ill and suicidal. They require — and deserve — our best diagnostic and treatment efforts.
We need to get the message out that for every death by suicide there is a cohort of bereaved family members who themselves become ill and suicidal. They require — and deserve — our best diagnostic and treatment efforts.
We need to get the message out...
05/27/2016
Psych Congress Network

Advertisement

Blog
When Physician-Patients Push Back Against “Split Treatment”
05/11/2016
Word on the street is that many physicians do not like undergoing split treatment when they become the patient.
Word on the street is that many physicians do not like undergoing split treatment when they become the patient.
Word on the street is that many...
05/11/2016
Psych Congress Network

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use